CD36 and obesity disorder: As obesity is strongly associated with an increase in circulating free fatty acids (17), cellular derivatives of which are established inhibitors of Kir2.1(15, 16), we further hypothesized that VAT-mediated impairment of Kir2.1 is dependent on an increase in endothelial CD36 function.